The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
NA ID: ALA4793710
Chembl Id: CHEMBL4793710
PubChem CID: 67735494
Max Phase: Preclinical
Molecular Formula: C40H65N5O5
Molecular Weight: 695.99
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@@H]4[C@@]5(COC[C@]4(C)[C@@H](OC[C@](C)(N)C(C)(C)C)[C@H](n4ncnc4C(N)=O)C5)C3=CC[C@@]2(C)[C@@H]1C(=O)O
Standard InChI: InChI=1S/C40H65N5O5/c1-23(2)24(3)35(7)16-17-37(9)25-12-13-28-36(8)19-49-21-40(28,26(25)14-15-38(37,10)29(35)33(47)48)18-27(45-32(31(41)46)43-22-44-45)30(36)50-20-39(11,42)34(4,5)6/h14,22-25,27-30H,12-13,15-21,42H2,1-11H3,(H2,41,46)(H,47,48)/t24-,25+,27-,28+,29-,30+,35-,36+,37-,38+,39+,40+/m1/s1
Standard InChI Key: SBOWFTBCBBACFO-MIFJZEKZSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 695.99Molecular Weight (Monoisotopic): 695.4986AlogP: 6.66#Rotatable Bonds: 8Polar Surface Area: 155.58Molecular Species: ZWITTERIONHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 4.55CX Basic pKa: 9.75CX LogP: 3.32CX LogD: 3.32Aromatic Rings: 1Heavy Atoms: 50QED Weighted: 0.26Np Likeness Score: 1.31
References 1. Apgar JM,Wilkening RR,Parker DL,Meng D,Wildonger KJ,Sperbeck D,Greenlee ML,Balkovec JM,Flattery AM,Abruzzo GK,Galgoci AM,Giacobbe RA,Gill CJ,Hsu MJ,Liberator P,Misura AS,Motyl M,Kahn JN,Powles M,Racine F,Dragovic J,Fan W,Kirwan R,Lee S,Liu H,Mamai A,Nelson K,Peel M. (2020) MK-5204: An orally active β-1,3-glucan synthesis inhibitor., 30 (17): [PMID:32738971 ] [10.1016/j.bmcl.2020.127357 ]